Marguerite L Monogue

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Cystic Fibrosis

Pseudomonas Aeruginosa

Infectious Diseases

Genetic Diversity

Top Venues

Microbiology spectrum

Pharmacotherapy

JAC-antimicrobial resistance

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Marguerite L Monogue, Dhara Desai, Christine A Pybus, James M Sanders, Andrew E Clark, David E Greenberg
In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients. Microbiology spectrum (2023)
Marguerite L Monogue, James M Sanders, Christine A Pybus, Jiwoong Kim, Xiaowei Zhan, Andrew E Clark, David E Greenberg
Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections. JAC-antimicrobial resistance 5 (4) (2023)
Daniel N Maxwell, Jiwoong Kim, Christine A Pybus, Leona White, Richard J Medford, Laura M Filkins, Marguerite L Monogue, Meredith M Rae, Dhara Desai, Andrew E Clark, Xiaowei Zhan, David E Greenberg
Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimens. The Journal of antimicrobial chemotherapy 77 (12) (2022)
Marguerite L Monogue, Emily L Heil, Samuel L Aitken, Jason M Pogue
The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 41 (10) (2021)